Original Research

Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study

Zhou Y, Chen M, Liu L, Chen Z

Diabetes, Metabolic Syndrome and Obesity 2022, 15:155-163

Published Date: 13 January 2022